 |
|
|
| |
Comparable effectiveness of Raltegravir-based dual therapy
versus other regimes in patients switched for maintenance
|
| |
| |
EACS Conference 2019, Basel, Switzerland, November 6-9, 2019
Reported by Jules Levin
K Martin1, B Funke1, T Wuensche2, T Lutz3, H Jaeger4, V Witte1
1MSD Sharp & Dohme GmbH, Medical Affairs, Haar, Germany; 2Praxis Wuensche, Berlin, Germany; 3Infektiologikum Frankfurt, Frankfurt am Main, Germany; 4MVZ Karlsplatz, HIV Research and Clinical Care Centre Munich, Germany
|
| |
|
|
|
|
|
